Oura, which sells smart rings and subscriptions for personalized health insights, postponed its IPO on Tuesday. The company stated in a press release that, despite strong demand, it was postponing due to uncertainty in the IPO market. It had filed to raise $2.1 billion by offering 50 million shares (73% secondary) at a price range of $40 to $44.
The San Francisco, CA-based company was founded in 2013 and booked $1.4 billion in revenue for the 12 months ended June 30, 2026. It had planned to list on the Nasdaq under the symbol OURA. Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company, Jefferies, BofA Securities, Barclays, Wells Fargo Securities, Citizens JMP, KeyBanc Capital Markets, Guggenheim Securities, Canaccord Genuity, Needham & Co., Raymond James, Rothschild, Truist Securities, and William Blair were set to be the joint bookrunners on the deal.
